» Articles » PMID: 20444243

Randomized Controlled Trial of Live Lactobacillus Acidophilus Plus Bifidobacterium Bifidum in Prophylaxis of Diarrhea During Radiotherapy in Cervical Cancer Patients

Overview
Journal Radiat Oncol
Publisher Biomed Central
Specialties Oncology
Radiology
Date 2010 May 7
PMID 20444243
Citations 89
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Radiation-induced diarrhea is frequently observed during pelvic radiotherapy. This study was performed to determine the ability of a probiotic containing live lactobacillus acidophilus plus bifidobacterium bifidum to reduce the incidence of radiation-induced diarrhea in locally advanced cervical cancer patients.

Methods: Patients who were undergoing pelvic radiotherapy concurrent with weekly cisplatin were randomly assigned to a study drug or placebo, in a double-blind study. Diarrhea was graded weekly according the Common Toxicity Criteria (CTC) system. Stool consistency and white and red blood cell count in stool were also assessed. The primary endpoint was to reduce the incidence of diarrhea, defined by a CTC grade 2 or more, and the need for anti-diarrheal medication.

Results: A total of 63 patients were enrolled. Grade 2 -3 diarrhea was observed in 45% of the placebo group (n = 31) and 9% of the study drug group (n = 32) (p = 0.002). Anti-diarrheal medication use was significantly reduced in the placebo group (p = 0.03). The patients in the study drug group had a significantly improved stool consistency (p < 0.001).

Conclusions: Live lactobacillus acidophilus plus bifidobacterium bifidum reduced the incidence of radiation-induced diarrhea and the need for anti-diarrheal medication and had a significant benefits on stool consistency.

Citing Articles

Gut microbiota as a new target for anticancer therapy: from mechanism to means of regulation.

Sun J, Song S, Liu J, Chen F, Li X, Wu G NPJ Biofilms Microbiomes. 2025; 11(1):43.

PMID: 40069181 PMC: 11897378. DOI: 10.1038/s41522-025-00678-x.


Immuno-oncological Challenges and Chemoresistance in Veterinary Medicine: Probiotics as a New Strategic Tool.

Nisar M, Yan T, Cai Y, Wan C Probiotics Antimicrob Proteins. 2025; .

PMID: 39954194 DOI: 10.1007/s12602-025-10468-8.


The Bidirectional Impact of Cancer Radiotherapy and Human Microbiome: Microbiome as Potential Anti-tumor Treatment Efficacy and Toxicity Modulator.

Palkovsky M, Modrackova N, Neuzil-Bunesova V, Liberko M, Soumarova R In Vivo. 2024; 39(1):37-54.

PMID: 39740900 PMC: 11705129. DOI: 10.21873/invivo.13803.


Human microbiome in post-acute COVID-19 syndrome (PACS).

Fallah A, Sedighian H, Kachuei R, Fooladi A Curr Res Microb Sci. 2024; 8:100324.

PMID: 39717208 PMC: 11665312. DOI: 10.1016/j.crmicr.2024.100324.


Prevention of Radiotherapy-Induced Enteropathy by Probiotics (PREP): Double-Blind Randomized Placebo-Controlled Trial.

Jo Y, Kim Y, Lee S, Kim Y Curr Oncol. 2024; 31(10):5889-5895.

PMID: 39451742 PMC: 11506454. DOI: 10.3390/curroncol31100438.


References
1.
Van Niel C, Feudtner C, Garrison M, Christakis D . Lactobacillus therapy for acute infectious diarrhea in children: a meta-analysis. Pediatrics. 2002; 109(4):678-84. DOI: 10.1542/peds.109.4.678. View

2.
Urbancsek H, Kazar T, Mezes I, Neumann K . Results of a double-blind, randomized study to evaluate the efficacy and safety of Antibiophilus in patients with radiation-induced diarrhoea. Eur J Gastroenterol Hepatol. 2001; 13(4):391-6. DOI: 10.1097/00042737-200104000-00015. View

3.
Vanderhoof J, WHITNEY D, Antonson D, Hanner T, Lupo J, Young R . Lactobacillus GG in the prevention of antibiotic-associated diarrhea in children. J Pediatr. 1999; 135(5):564-8. DOI: 10.1016/s0022-3476(99)70053-3. View

4.
Henriksson R, Franzen L, Sandstrom K, Nordin A, Arevarn M, Grahn E . Effects of active addition of bacterial cultures in fermented milk to patients with chronic bowel discomfort following irradiation. Support Care Cancer. 1995; 3(1):81-3. DOI: 10.1007/BF00343926. View

5.
Siitonen S, Vapaatalo H, Salminen S, Gordin A, Saxelin M, Wikberg R . Effect of Lactobacillus GG yoghurt in prevention of antibiotic associated diarrhoea. Ann Med. 1990; 22(1):57-9. DOI: 10.3109/07853899009147243. View